About Ally Therapeutics

About company

Ally Therapeutics solves the immune response barriers for gene therapy. They are dedicated to solving the immune response issues that limit the safety and efficacy of in vivo gene therapies. It is backed by ARCH, Alta, and UCB Ventures. The company is a new biotech company based in Cambridge, Massachusetts, and was founded in 2018.